The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition

Journal of Hepatology
Gonzalo CrespoMiquel Navasa

Abstract

The efficacy of direct-acting antivirals (DAAs) has dramatically changed the prognosis of patients with chronic hepatitis C. We aimed to evaluate the impact of DAA therapy on the composition of the liver transplant (LT) waiting list and the early post-transplant survival. We evaluated all patients admitted to the waiting list for a primary LT between 1st January 2008 and 31st of December 2016 in Catalonia, Spain. Time span was divided into two periods according to the availability of different antiviral therapies: 2008-2013 (interferon-based therapies) and 2014-2016 (DAA). Changes in the indications of LT and the aetiology of liver disease, as well as post-LT patient survival, were evaluated according to the year of inclusion and transplantation, respectively. We included 1,483 patients. Admissions in the waiting list for hepatitis C virus (HCV)-related liver disease decreased significantly, from 47% in 2008-2013 to 35% in 2014-2016 (p <0.001), particularly because of a reduction in patients with decompensated cirrhosis. In contrast, NASH-related inclusions increased from 4% to 7% (p = 0.003). Three-year post-LT patient survival increased significantly in the second period in the whole cohort (82% vs. 91%, p = 0.002), because o...Continue Reading

Citations

Feb 13, 2019·Transplantation·Christine E Haugen, Dorry L Segev
Mar 14, 2019·Transplant International : Official Journal of the European Society for Organ Transplantation·Sumant S AroraAshwani K Singal
Jul 31, 2019·Alimentary Pharmacology & Therapeutics·Enric Reverter
Mar 21, 2018·MMW Fortschritte der Medizin·Christine Starostzik
Jun 4, 2020·Annals of Gastroenterological Surgery·Masahiro OhiraHideki Ohdan
Aug 15, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Tommy IvanicsShunji Nagai
Dec 28, 2019·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·Joaquín CabezasJavier Crespo
May 10, 2020·Journal of Clinical Medicine·Enrico GringeriFrancesco Paolo Russo
Jul 20, 2019·Nature Reviews. Gastroenterology & Hepatology·Jeffrey V LazarusMaria Buti
Sep 30, 2020·Transplant International : Official Journal of the European Society for Organ Transplantation·David ChoiCostica Aloman
Nov 20, 2020·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·Cristina BurguiJesús Castilla
Jan 11, 2021·Transplant International : Official Journal of the European Society for Organ Transplantation·Shunji NagaiDilip Moonka
Feb 8, 2021·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Gonzalo Crespo
Dec 24, 2018·Journal of Hepatology·François DurandClaire Francoz
Jul 23, 2020·Journal of Hepatology·Sergio Rodríguez-TajesXavier Forns
Apr 27, 2021·Expert Opinion on Pharmacotherapy·Carol StanciuAnca Trifan
Sep 6, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy PapalucaAlexander J Thompson
Mar 1, 2021·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Amare AregayHeiner Wedemeyer
Oct 9, 2021·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Jess HowellPaul Gow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.